SCHEMBL707799

SCHEMBL707799

C=CCOC(=O)C1CCCN1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 4/20 0.36
DPP8 Q6V1X1 2/20 0.36
DPP9 Q86TI2 2/20 0.36
DPP7 Q9UHL4 2/20 0.36
FAP Q12884 1/20 0.36
ALDH1A1 P00352 1/20 0.36
GAA P10253 1/20 0.36
NOS2 P35228 2/20 0.36
NOS3 P29474 1/20 0.36
NOS1 P29475 1/20 0.36
PRCP P42785 2/20 0.36
ELANE P08246 1/20 0.33
CYP3A4 P08684 1/20 0.33
HTR2C P28335 2/20 0.32
POLB P06746 1/20 0.32
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32
HTR2B P41595 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL351761 1.00 DPP4 (0.36) DPP4DPP8DPP9DPP7FAP
SCHEMBL6578863 1.00 DPP4 (0.36) DPP4DPP8DPP9DPP7FAP
Hydrochloric Acid SCHEMBL10615023 0.98 DPP4 (0.36) DPP4DPP8DPP9DPP7FAP
Hydrochloric Acid SCHEMBL10615017 0.98 DPP4 (0.36) DPP4DPP8DPP9DPP7FAP
SCHEMBL15886548 0.95 ALDH1A1 (0.38) DPP4DPP8DPP9DPP7FAP
SCHEMBL8521036 0.95 ALDH1A1 (0.38) DPP4DPP8DPP9DPP7FAP
SCHEMBL13278810 0.91 ALDH1A1 (0.36) DPP4ALDH1A1GAACYP3A4POLB
SCHEMBL8726681 0.87 ALDH1A1 (0.33) DPP4DPP8DPP9DPP7FAP
SCHEMBL30713421 0.84 ALDH1A1 (0.42) DPP4ALDH1A1GAANOS2NOS3
SCHEMBL21696620 0.83 DPP4 (0.35) DPP4DPP8DPP9DPP7FAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118267309-A Essence composition containing chamomile extract and preparation method thereof 广州中科医疗美容仪器有限公司 2024-07-02 CN claimed
CN-114560887-A Preparation method of intermediate for preparing orlistat 安徽美致诚药业有限公司 2022-05-31 CN claimed
EP-1496891-B1 METHODS FOR MODULATING PHOTOTOXICITY UNIV ARIZONA STATE (US) 2011-07-20 EP claimed
US-6992071-B2 Methods for modulating phototoxicity BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2006-01-31 US claimed
EP-1496891-A2 METHODS FOR MODULATING PHOTOTOXICITY University Of Arizona (US) 2005-01-19 EP claimed
US-20030223941-A1 Methods for modulating phototoxicity NIADYNE, INC. 2003-12-04 US claimed
WO-2003088909-A2 METHODS FOR MODULATING PHOTOTOXICITY UNIVERSITY OF ARIZONA (US) 2003-10-30 WO claimed
EP-0372484-B1 Condensed benzene derivative ZERIA PHARM CO LTD (JP) 1994-10-26 EP claimed
CN-112469306-B Composition, artificial nail composition, nail decorating material, artificial nail, storage container, image forming apparatus, and image forming method 株式会社理光 2024-07-05 CN disclosed
CN-118267309-A Essence composition containing chamomile extract and preparation method thereof 广州中科医疗美容仪器有限公司 2024-07-02 CN disclosed
CN-118267309-A Essence composition containing chamomile extract and preparation method thereof 广州中科医疗美容仪器有限公司 2024-07-02 CN disclosed
CN-118234729-A Process for preparing bicyclic glycine-proline compounds and monocyclic glycine-proline intermediates thereof 诺仁制药有限公司 2024-06-21 CN disclosed
WO-2023217590-A1 POLYAMIDE MICROCAPSULES FIRMENICH SA (CH) 2023-11-16 WO disclosed
CN-116615411-A Process for producing peptide compound containing N-substituted amino acid residue 中外制药株式会社 2023-08-18 CN disclosed
US-6168912-B1 CONVERTING IN PARALLEL, A SET OF AT LEAST TWO DIFFERENT ALPHA-ALLYL CARBONYL MONOMERS OF DEFINED STRUCTURE, THEN OLIGOMERIZING THROUGH A HETEROATOM MARTEK BIOSCIENCES CORPORATION 2001-01-02 US disclosed
EP-0372484-B1 Condensed benzene derivative ZERIA PHARM CO LTD (JP) 1994-10-26 EP disclosed
US-5028604-A Cognition Activators ZERIA PHARMACEUTICAL CO., LTD. (JP) 1991-07-02 US disclosed
US-4992541-A Antiinflammatory, antidegenerative agents MERCK & CO., INC. (US) 1991-02-12 US disclosed
EP-0411929-A1 A process for the preparation of 1,1-dioxo-7-substituted cephems MERCK & CO. INC. (US) 1991-02-06 EP disclosed
EP-0372484-A2 Condensed benzene derivative ZERIA PHARMACEUTICAL CO., LTD. (JP) 1990-06-13 EP disclosed